Amplia Therapeutics (INNMF, $0.05) was a top loser over the last three months, falling -1 to $0.05 per share. A.I.dvisor analyzed 849 stocks in the Biotechnology Industry for the 3-month period ending April 4, 2025, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.